Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The Longevity Letter One short, sourced note each week
Key Takeaways Retatrutide is a novel drug that targets various metabolic pathways to aid visceral fat reduction and enhance weight management in people with obesity
[4] [5] By activating GLP-1 receptors, retatrutide is thought to help stimulate insulin secretion, suppress appetite, and slow gastric emptying effects that may contribute to reduced calorie intake and improved blood glucose control
This triple-action mechanism distinguishes it from existing approved agents such as semaglutide (a GLP-1 receptor agonist, approved in the UK as Wegovy and Ozempic) and tirzepatide (a dual GIP/GLP-1 agonist, approved as Mounjaro)
These assist in boosting antioxidant levels within the body while also providing healthy, glowing skin
Strategic combinations target multiple mechanisms for enhanced results
US$ 27.26
US$ 24.07
US$ 20.63
US$ 21.85
US$ 28.94
US$ 24.93
